ICCM — IceCure Medical Ltd.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1584371 · Israel
Last close
$0.23
Market Cap
$18.40M
52W High
$0.74
52W Low
$0.22
ADV30
598,196
Next earnings
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 911,000 295,000 -4,247,000 -4,274,000 13,303,000 8,115,000 4,809,000
Dec 2025 1,279,000 600,000 -4,216,000 -4,246,000 13,888,000 8,897,000 4,837,000
Sep 2025 850,000 277,000 -3,836,000 -3,859,000 15,078,000 4,971,000 5,772,000
Jun 2025 525,000 131,000 -3,385,000 -3,364,000 10,589,000 5,383,000 7,698,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-14,574,000
Investing CF
$-36,000
Financing CF
$15,834,000
CapEx
$-36,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.06
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-120,436,000
Inventory
$2,625,000
Receivables
$544,000
ST Investments
$5,034,000
EBIT TTM
$-15,094,000
Pretax Income TTM
$-15,057,000
Interest Exp TTM
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,565,000
EBITDA
$-15,409,000
Free Cash Flow
$-8,879,375
Enterprise Value
$11,101,311
Total Cash
$8,115,000
Total Debt
$139,000
Shares Out
81,237,799
Trailing EPS
$-0.24
Book Value
$0.10
ROE
-217.2%
ROA
-80.3%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 3,379,000 -15,094,000 -15,057,000 13,888,000 4,837,000 -14,574,000
Dec 2024 3,291,000 -15,696,000 -15,318,000 12,576,000 5,675,000 -12,563,000
Dec 2023 3,229,000 -15,576,000 -14,652,000 16,410,000 4,247,000 -12,550,000
Dec 2022 3,085,000 -16,739,000 -16,978,000 30,188,000 4,766,000 -14,292,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.10

Peers — same industry

TickerNameMarket CapLastDaily %
GTHP GUIDED THERAPEUTICS INC $18.34M $0.19
IRIX IRIDEX CORP $18.10M $1.04
LFWD Lifeward Ltd. $19.39M $6.98
OSRH OSR Holdings, Inc. $17.38M $0.50
ADGM Adagio Medical Holdings, Inc. $16.66M $0.75

News headlines (Yahoo Finance, 1h cache)

Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ...
2026-05-21 01:00 · Yahoo
IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked
2026-05-19 12:30 · Yahoo
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
2026-05-13 20:30 · Yahoo
IceCure (ICCM) Q1 2026 Earnings Transcript
2026-05-12 16:11 · Yahoo
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates
2026-05-12 13:40 · Yahoo
IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America
2026-05-12 12:30 · Yahoo
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates
2026-05-07 23:05 · Yahoo
IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026
2026-05-06 12:30 · Yahoo
IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market
2026-05-05 12:30 · Yahoo
IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025
2026-04-21 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.